查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585666

生物製程驗證市場：按測試類型、製程組件和最終用戶分類 - 2025-2030 年全球預測

Bioprocess Validation Market by Test Type, Process Component, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年生物製程驗證市場價值為3.9547億美元，預計到2024年將達到4.5357億美元，複合年成長率為14.78%，到2030年將達到10.3834億美元。

生物程序驗證是生物技術和製藥行業的關鍵組成部分，確保生技藥品生產中涉及的工藝始終有效，並始終生產出符合指定規格和品質屬性的產品。 FDA 和 EMA 等機構提出的嚴格監管要求產生了對生物製程驗證的需求，需要嚴格的製程一致性和產品安全性證據。生物製程驗證的主要發展涵蓋藥物開發和製造的各個階段，從種植和收穫到精製和配方，並針對生物製藥公司、契約製造組織 (CMO) 和研發機構等關鍵最終用戶。市場成長受到生技藥品和生物相似藥需求增加、生物製藥研發投資以及對個人化醫療日益關注的顯著影響。此外，製程分析技術 (PAT) 和自動化的技術進步為提高生物製程效率和確保合規性提供了巨大的潛在機會。公司可以透過投資用於即時監控和控制生物過程的創新解決方案以及整合人工智慧和機器學習來進行預測分析和品管系統來利用這些機會。然而，市場面臨著許多挑戰，包括高昂的初始成本、複雜的製程設計以及抑制創新並減慢上市時間的法律規範。應對這些挑戰需要提高具有成本效益的驗證技術並開發強大的標準化通訊協定。最佳創新領域包括探索連續製造方法、引入用於預測生物加工的先進資料分析以及改進一次性技術以提高靈活性並減少交叉污染風險。這個市場的特點是動態性和技術快速發展，需要不斷調整和前瞻性策略，才能成功駕馭競爭格局並推動永續成長。

主要市場統計
基準年[2023] 3.9547 億美元
預測年份 [2024] 45357萬美元
預測年份 [2030] 1,038,340,000 美元
複合年成長率（%） 14.78%

市場動態：快速發展的生物製程驗證市場的關鍵市場洞察

供需的動態交互作用正在改變生物製程驗證市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 精確的安全和品質法規
    • 生物製藥需求不斷成長
    • 生物製程驗證外包需求不斷成長
  • 市場限制因素
    • 生物製程驗證高成本
  • 市場機會
    • 開發下一代生物產品的新驗證方法
    • 細胞和基因療法在醫療保健領域的興起
  • 市場挑戰
    • 驗證過程中的功能問題

波特五力：駕馭生物製程驗證市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解生物製程驗證市場的外部影響

外部宏觀環境因素在塑造生物過程驗證市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解生物製程驗證市場的競爭格局

生物過程驗證市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣生物製程驗證市場供應商的績效評估

FPNV 定位矩陣是評估生物製程驗證市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了生物過程驗證市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，生物程序驗證市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 精確的安全和品質法規
      • 生物製藥需求增加
      • 外包生物製程驗證的需求不斷成長
    • 抑制因素
      • 生物製程驗證成本高
    • 機會
      • 開發下一代生物產品的新檢驗方法
      • 細胞和基因療法在醫療保健領域的出現
    • 任務
      • 檢驗過程的功能問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章按測試類型分類的生物製程驗證市場

  • 相容性測試服務
  • 萃取物或可浸出物測試服務
  • 完整性測試服務
  • 微生物檢測服務

第7章依製程組成部分分類的生物製程驗證市場

  • 反應器
  • 濾芯
  • 冷凍/解凍加工袋
  • 媒體容器和袋子
  • 混合系統
  • 傳輸系統

第 8 章生物製程驗證市場：依最終用戶分類

  • 生技公司
  • 合約開發和製造組織
  • 製藥公司

第9章美洲生物製程驗證市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太生物製程驗證市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的生物製程驗證市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Almac Group
  • BiOZEEN
  • Eurofins Scientific SE
  • Hangzhou Anow Microfiltration Co., Ltd.
  • Hangzhou Cobetter Filtration Equipment Co., Ltd.
  • Intertek Group PLC
  • Meissner Filtration Products, Inc.
  • Merck KGaA
  • Nelson Laboratories, LLC by Sotera Health company
  • Pall Corporation
  • Porvair PLC
  • Sartorius AG
  • SGS SA
  • Thermo Fisher Scientific, Inc.
  • West Pharmaceutical Services, Inc.
Product Code: MRR-4316E4E891B6

The Bioprocess Validation Market was valued at USD 395.47 million in 2023, expected to reach USD 453.57 million in 2024, and is projected to grow at a CAGR of 14.78%, to USD 1,038.34 million by 2030.

Bioprocess validation encompasses a critical component in the biotechnology and pharmaceutical industries, focusing on ensuring that processes involved in the production of biologics are consistent, effective, and capable of consistently producing products meeting predetermined specifications and quality attributes. The necessity of bioprocess validation arises from the stringent regulatory requirements imposed by agencies like the FDA and EMA, demanding rigorous evidence of process consistency and product safety. Its applications span across various stages of drug development and manufacturing, from culture growth and harvest to purification and formulation, impacting key end-users such as biopharmaceutical companies, contract manufacturing organizations (CMOs), and R&D institutes. Market growth is predominantly influenced by the increasing demand for biologics and biosimilars, investments in biopharmaceutical R&D, and the growing focus on personalized medicine. Additionally, technological advancements in process analytical technologies (PAT) and automation offer significant potential opportunities for enhancing bioprocess efficiencies and ensuring compliance. Companies can capitalize on these opportunities by investing in innovative solutions for real-time monitoring and control of bioprocesses, as well as integrating artificial intelligence and machine learning for predictive analytics and quality management systems. However, the market faces challenges such as high initial costs, complexities in process design, and stringent regulatory frameworks that can stifle innovation and slow down time-to-market. Addressing these challenges requires advancements in cost-effective validation techniques and the development of robust standardized protocols. The best areas for innovation include the exploration of continuous manufacturing methods, incorporation of advanced data analytics for predictive bioprocessing, and improved single-use technologies to enhance flexibility and reduce cross-contamination risks. The market, characterized by its dynamic nature and rapid technological evolution, demands continuous adaptation and forward-thinking strategies to successfully navigate the competitive landscape and drive sustainable growth.

KEY MARKET STATISTICS
Base Year [2023] USD 395.47 million
Estimated Year [2024] USD 453.57 million
Forecast Year [2030] USD 1,038.34 million
CAGR (%) 14.78%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bioprocess Validation Market

The Bioprocess Validation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Precise safety and quality regulations
    • Rising demand for biopharmaceuticals
    • Growing need for outsourcing bioprocess validation
  • Market Restraints
    • High cost of bioprocess validation
  • Market Opportunities
    • Development of new validation methods for next-generation bioproducts
    • Emergence of cell & gene therapy in the healthcare sector
  • Market Challenges
    • Functional issues with validation processes

Porter's Five Forces: A Strategic Tool for Navigating the Bioprocess Validation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bioprocess Validation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bioprocess Validation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bioprocess Validation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bioprocess Validation Market

A detailed market share analysis in the Bioprocess Validation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bioprocess Validation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bioprocess Validation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bioprocess Validation Market

A strategic analysis of the Bioprocess Validation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bioprocess Validation Market, highlighting leading vendors and their innovative profiles. These include Almac Group, BiOZEEN, Eurofins Scientific SE, Hangzhou Anow Microfiltration Co., Ltd., Hangzhou Cobetter Filtration Equipment Co., Ltd., Intertek Group PLC, Meissner Filtration Products, Inc., Merck KGaA, Nelson Laboratories, LLC by Sotera Health company, Pall Corporation, Porvair PLC, Sartorius AG, SGS S.A., Thermo Fisher Scientific, Inc., and West Pharmaceutical Services, Inc..

Market Segmentation & Coverage

This research report categorizes the Bioprocess Validation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Test Type, market is studied across Compatibility Testing Services, Extractables or Leachables Testing Services, Integrity Testing Services, and Microbiological Testing Services.
  • Based on Process Component, market is studied across Bioreactors, Filter Elements, Freezing & Thawing Process Bags, Media Containers & Bags, Mixing Systems, and Transfer Systems.
  • Based on End User, market is studied across Biotechnology Companies, Contract Development & Manufacturing Organizations, and Pharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Precise safety and quality regulations
      • 5.1.1.2. Rising demand for biopharmaceuticals
      • 5.1.1.3. Growing need for outsourcing bioprocess validation
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of bioprocess validation
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of new validation methods for next-generation bioproducts
      • 5.1.3.2. Emergence of cell & gene therapy in the healthcare sector
    • 5.1.4. Challenges
      • 5.1.4.1. Functional issues with validation processes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bioprocess Validation Market, by Test Type

  • 6.1. Introduction
  • 6.2. Compatibility Testing Services
  • 6.3. Extractables or Leachables Testing Services
  • 6.4. Integrity Testing Services
  • 6.5. Microbiological Testing Services

7. Bioprocess Validation Market, by Process Component

  • 7.1. Introduction
  • 7.2. Bioreactors
  • 7.3. Filter Elements
  • 7.4. Freezing & Thawing Process Bags
  • 7.5. Media Containers & Bags
  • 7.6. Mixing Systems
  • 7.7. Transfer Systems

8. Bioprocess Validation Market, by End User

  • 8.1. Introduction
  • 8.2. Biotechnology Companies
  • 8.3. Contract Development & Manufacturing Organizations
  • 8.4. Pharmaceutical Companies

9. Americas Bioprocess Validation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bioprocess Validation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bioprocess Validation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Almac Group
  • 2. BiOZEEN
  • 3. Eurofins Scientific SE
  • 4. Hangzhou Anow Microfiltration Co., Ltd.
  • 5. Hangzhou Cobetter Filtration Equipment Co., Ltd.
  • 6. Intertek Group PLC
  • 7. Meissner Filtration Products, Inc.
  • 8. Merck KGaA
  • 9. Nelson Laboratories, LLC by Sotera Health company
  • 10. Pall Corporation
  • 11. Porvair PLC
  • 12. Sartorius AG
  • 13. SGS S.A.
  • 14. Thermo Fisher Scientific, Inc.
  • 15. West Pharmaceutical Services, Inc.

LIST OF FIGURES

  • FIGURE 1. BIOPROCESS VALIDATION MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPROCESS VALIDATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BIOPROCESS VALIDATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BIOPROCESS VALIDATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPROCESS VALIDATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPROCESS VALIDATION MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY COMPATIBILITY TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY EXTRACTABLES OR LEACHABLES TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY INTEGRITY TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY MICROBIOLOGICAL TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY FILTER ELEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY FREEZING & THAWING PROCESS BAGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY MEDIA CONTAINERS & BAGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY MIXING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY TRANSFER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOPROCESS VALIDATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. BIOPROCESS VALIDATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. BIOPROCESS VALIDATION MARKET, FPNV POSITIONING MATRIX, 2023